Arsenal boss Arsene Wenger insists he will not renew his interest in Bordeaux striker Marouane Chamakh in January.
The Morocco striker, out of contract at the end of the season, was heavily linked with a move to the Emirates Stadium throughout the summer.
Arsenal had a bid turned down for Chamakh and Wenger had previously hinted he could make another offer during the winter transfer window.
But Wenger claims he's happy with his current squad and has backed the likes of Eduardo, Nicklas Bendtner and Robin van Persie to bag the Gunners' goals this season.
"No, we don't go anywhere," said the Gunners' boss. "We have plenty of strikers. Eduardo has made a recovery and Nicklas Bendtner has extended his contract; that means we have strikers."
Meanwhile Wenger also revealed he did not reinvest his summer transfer profits because he believes he has the squad to compete with the best in the Premier League.
The Gunners boss sold Emmanuel Adebayor and Kolo Toure to Manchester City in the summer for an estimated total fee of £41million.
Thomas Vermaelen was the only arrival as Ajax received £10m, leaving an estimated profit of £31m in transfer income.
Wenger has been told by the Arsenal hierarchy that he has a set amount of money available, but the Frenchman does not feel it is neccesary to spend.
He told Arsenal's official website: "We sold Kolo and Adebayor but bought Vermaelen.
"That money is for me. I know how much I have and I am happy with it.
"But last week we played Wigan. We won 4-0 and on the bench I had (Nicklas) Bendtner. (Theo) Walcott, (Andrey) Arshavin, (Samir) Nasri, Denilson and (Johan) Djourou were not playing.
"Do we have the squad to compete with the other (Big) four? I say yes. We have an unbelievable squad. Where do you put all the talented players?
"I believe we can show that we are not in a position where we need to buy. For me, we are in a position where we want to transform our potential into being real Premier League contenders."
Friday, September 25, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment